<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3264</number>
    <updateDate>2023-01-11T20:47:24Z</updateDate>
    <updateDateIncludingText>2023-01-11T20:47:24Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2007-07-31</introducedDate>
    <congress>110</congress>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2007-07-31T13:06:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2007-08-02</actionDate>
        <text>Sponsor introductory remarks on measure. (CR E1689-1690)</text>
        <type>IntroReferral</type>
        <actionCode>B00100</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-07-31</actionDate>
        <text>Referred to the House Committee on Ways and Means.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2007-07-31</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2007-07-31</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001162</bioguideId>
        <fullName>Rep. Schwartz, Allyson Y. [D-PA-13]</fullName>
        <firstName>Allyson</firstName>
        <lastName>Schwartz</lastName>
        <party>D</party>
        <state>PA</state>
        <middleName>Y.</middleName>
        <district>13</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B000755</bioguideId>
        <fullName>Rep. Brady, Kevin [R-TX-8]</fullName>
        <firstName>KEVIN</firstName>
        <lastName>BRADY</lastName>
        <party>R</party>
        <state>TX</state>
        <district>8</district>
        <sponsorshipDate>2007-07-31</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>N000015</bioguideId>
        <fullName>Rep. Neal, Richard E. [D-MA-2]</fullName>
        <firstName>RICHARD</firstName>
        <lastName>NEAL</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>E.</middleName>
        <district>2</district>
        <sponsorshipDate>2007-07-31</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H000528</bioguideId>
        <fullName>Rep. Herger, Wally [R-CA-2]</fullName>
        <firstName>WALLY</firstName>
        <lastName>HERGER</lastName>
        <party>R</party>
        <state>CA</state>
        <district>2</district>
        <sponsorshipDate>2007-07-31</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Biomedical engineering</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Finance and Financial Sector</name>
        </item>
        <item>
          <name>Health</name>
        </item>
        <item>
          <name>Income tax</name>
        </item>
        <item>
          <name>Investment tax credit</name>
        </item>
        <item>
          <name>Investments</name>
        </item>
        <item>
          <name>Losses</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Orphan drugs</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Research and development tax credit</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Small business</name>
        </item>
        <item>
          <name>Tax credits</name>
        </item>
        <item>
          <name>Tax deductions</name>
        </item>
        <item>
          <name>Tax deferral</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Taxation</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2007-07-31</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2007-09-10T13:53:01Z</updateDate>
        <text><![CDATA[ <p>American Life Sciences Competitiveness Act of 2007 - Amends the Internal Revenue Code to allow biomedical research corporations to: (1) engage in investment activity involving shifts in ownership without incurring limitations on net operating loss carryforwards; (2) claim a full research and development tax credit for contract research expenses (currently, limited to 65%); (3) claim a business tax credit for 20% of eligible countermeasures research expenses (for biomedical threats); and (4) claim a tax-free rollover of gain from stock sales reinvested in another biomedical research corporation.</p><p>Expands the tax credit for clinical testing expenses for drugs to treat rare diseases (orphan drugs) to include expenses incurred after an application is made to the Food and Drug Administration (FDA) but before receipt of an orphan drug designation.</p><p>Allows individual taxpayers a 20% tax credit for equity investments in small biomedical research firms engaged in incubational research (i.e., research conducted prior to large-scale clinical trials). </p>]]></text>
      </summary>
    </summaries>
    <title>American Life Sciences Competitiveness Act of 2007</title>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Internal Revenue Code of 1986 to modernize the tax treatment of biomedical research corporations.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>American Life Sciences Competitiveness Act of 2007</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>American Life Sciences Competitiveness Act of 2007</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2007-07-31T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-110hr3264ih/xml/BILLS-110hr3264ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2007-08-02</actionDate>
      <text>Sponsor introductory remarks on measure. (CR E1689-1690)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
